Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.46 |
| ▸ | MC4R | P32245 | 1/20 | 0.46 |
| ▸ | APLNR | P35414 | 2/20 | 0.45 |
| ▸ | PRCP | P42785 | 1/20 | 0.45 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | CTSK | P43235 | 3/20 | 0.43 |
| ▸ | CTSH | P09668 | 1/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437187 | 0.95 | MC4R (0.49) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL31437197 | 0.92 | PRCP (0.47) | OPRM1OPRK1PRCPACE | |
| SCHEMBL31437213 | 0.88 | APLNR (0.48) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL31437191 | 0.86 | CTSL (0.50) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL31437193 | 0.86 | PRCP (0.51) | PRCPACE | |
| SCHEMBL31467764 | 0.85 | MC4R (0.50) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL31437172 | 0.83 | PRCP (0.44) | OPRM1OPRK1APLNRPRCPACE | |
| SCHEMBL29754679 | 0.83 | MC4R (0.50) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL31437199 | 0.83 | CTSL (0.54) | OPRM1OPRK1MC4RAPLNRC5AR1 | |
| SCHEMBL29634120 | 0.82 | CTSL (0.47) | OPRM1OPRK1MC4RAPLNRC5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |